|
"lim young suk"的相关文件
显示项目 1-9 / 9 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-03-14T23:45:21Z |
Review: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
|
Lim, Young Suk; Seto, Wai Kay; Kurosaki, Masayuki; Fung, Scott; JIA-HORNG KAO; Hou, Jinlin; Gordon, Stuart C.; Flaherty, John F.; Yee, Leland J.; Zhao, Yang; Agarwal, Kosh; Lampertico, Pietro |
| 臺大學術典藏 |
2021-03-14T23:24:36Z |
One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment
|
Tseng, Tai Chung; Choi, Jonggi; Nguyen, Mindie H.; Peng, Cheng Yuan; Siakavellas, Spyros; Papatheodoridis, George; CHIA-CHI WANG; Lim, Young Suk; Lai, Hsueh Chou; Trinh, Huy N.; Wong, Christopher; Wong, Clifford; Zhang, Jian; Li, Jiayi; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: A sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng;Lee, Youn-Jae;Heo, Jeong;Ahn, Sang-Hoon;Lim, Young-Suk;Peng, Cheng-Yuan;Chang, Ting-Tsung;Torbeyns, Anne;Hughes, Eric;Bhore, Rafia;Noviello, Stephanie; JIA-HORNG KAO; Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie |
| 國立成功大學 |
2016-11 |
Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)
|
Younossi, Zobair; Stepanova, Maria; Han, Kwang-Hyub; Lim, Young-Suk; Lee, Youn-Jae; Chuang, Wan-Long; Kao, Jia-Horng; Chien, Rong-Nan; Chang, Ting-Tsung; Peng, Cheng-Yuan |
| 國立成功大學 |
2016-10 |
Comparison of Health-Related Quality of Life (HRQL) in Asian Patients with Chronic Hepatitis C Treated with Interferon (IFN)-free Ribavirin (RBV)-Containing Regimens vs Interferon-free and Ribavirin-free Regimens
|
Younossi, Zobair M.;Stepanova, Maria;Han, Kwang-Hyub;Chuang, Wan-Long;Chan, Henry Lik-Yuen;Lim, Young-Suk;Chien, Rong-Nan;Ahn, Sang Hoon;Jeong, Sook-Hyang;Chang, Ting-Tsung;Paik, Seung Woon;Peng, Cheng-Yuan;Chu, Chi-Jen;Lee, Youn-Jae;Lai, Ching-Lung;Kao, Jia-Horng;Hunt, Sharon |
| 國立成功大學 |
2016-10 |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie |
| 國立臺灣大學 |
2016 |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Asian Patients with Genotype 1 HCV Infection Achieve 99% Sustained Virologic Response with 12 Weeks of Ledipasvir/Sofosbuvir Single Tablet Regimen: Integrated analysis of Phase 3 Multicenter Studies
|
Mizokami, Masashi; Chuang, Wan-Long; Han, Kwang-Hyub; Lim, Young-Suk; Yang, Jenny C.; De-Oertel, Shampa; Gao, Bing; Mo, Hongmei; Pang, Phillip S.; Knox, Steven J.; McHutchison, John G.; Omata, Masao; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Asian Patients with Chronic Genotype 2 HCV Infection Achieve 98% Sustained Virologic Response Following 12 Week administration of Sofosbuvir in Combination with Ribavirin: Integrated analysis of Phase 3 Multicenter Studies
|
Omata, Masao; Lim, Young-Suk; Chuang, Wan-Long; Kao, Jia-Horng; Gao, Bing; De-Oertel, Shampa; Yang, Jenny C.; Mo, Hongmei; Brainard, Diana M.; Knox, Steven J.; McHutchison, John G.; Mizokami, Masashi; Han, Kwang-Hyub; 高嘉宏 |
显示项目 1-9 / 9 (共1页)
1
每页显示[10|25|50]项目
|
